CurrentCardio
Get Weekly

Topic · page 31 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,201–1,240 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Eur Heart J

    Hypertrophic cardiomyopathy: prevalence of disease-specific red flags

    Cohort study

  2. Eur J Prev Cardiol

    Risk stratification with the Haemodynamic Gain Index and peak rate-pressure product in patients with chronic heart failure undergoing treadmill exercise testing

    Cohort study

  3. Eur J Prev Cardiol

    Increased fluid accumulation, reduced physical activity and heart rate variability during national holidays in patients with cardiac implantable electronic devices

    Cohort study

  4. JACC Heart Fail

    Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure

    Cohort study

  5. JACC Heart Fail

    Disparities Among Immigrants and Native Patients in Denmark With New-Onset Heart Failure With Reduced Ejection Fraction

    Cohort study

  6. JACC Heart Fail

    Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF

    Cohort study

  7. JACC Heart Fail

    Beta-Blockers and Long-Term Mortality in Takotsubo Syndrome: Results of the Multicenter GEIST Registry

    Cohort study

  8. Eur Heart J

    Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial

    Secondary analysis

  9. Eur J Prev Cardiol

    Association between Life’s Essential 8 and risk of heart failure: findings from the Kailuan study

    Cohort study

  10. Circulation

    Systematic Review, Meta-Analysis, and Population Study to Determine the Biologic Sex Ratio in Dilated Cardiomyopathy

    Meta-analysis

  11. JAMA Cardiol

    Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial

    Research article

  12. JAMA Cardiol

    Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial

    Secondary analysis

  13. JAMA Cardiol

    Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation

    Cross-sectional study

  14. JAMA Cardiol

    Transthyretin Tetramer Destabilization and Increased Mortality in the General Population

    Cohort study

  15. JACC Heart Fail

    Center- vs Home-Based Cardiac Rehabilitation in Patients With Heart Failure: EXIT-HF Randomized Controlled Trial

    Randomised controlled trial

  16. JACC Heart Fail

    Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial

    Secondary analysis

  17. Eur J Prev Cardiol

    Body mass index, regional adipose deposition, and clinical outcomes in non-ischaemic dilated cardiomyopathy: a prospective cohort study

    Cohort study

  18. Eur Heart J

    Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial

    Secondary analysis

  19. Eur J Heart Fail

    Rationale and Design of the FAIR-HF2-DZHK05 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure

    Trial design

  20. Eur J Heart Fail

    Continuous Risk Monitoring and Management of Heart Failure: Rationale and Design of the ALLEVIATE-HF Trial

    Trial design

  21. JACC Heart Fail

    Effects of Acute Phase Intensive Exercise Training in Patients With Acute Decompensated Heart Failure

    Randomised controlled trial

  22. JACC Heart Fail

    Adverse Pregnancy Outcomes and Long-Term Risk of Heart Failure in Women: National Cohort and Co-Sibling Study

    Cohort study

  23. JACC Heart Fail

    Elevated Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Acute Myocarditis

    Cohort study

  24. J Am Coll Cardiol

    Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial

    Secondary analysis

  25. Circulation

    Evidence-Based Application of Natriuretic Peptides in the Evaluation of Chronic Heart Failure With Preserved Ejection Fraction in the Ambulatory Outpatient Setting

    Diagnostic or prognostic study

  26. JACC CardioOncol

    Biomarkers to Predict Abnormal Technetium-99m Pyrophosphate Scans in Patients With Suspected Transthyretin Amyloidosis

    Cohort study

  27. Eur J Heart Fail

    Circulating Growth Differentiation Factor-15 Levels are Associated with Early Echocardiographic Signs of Diastolic Function Impairment in the STANISLAS Cohort: A 20-Year Follow-Up Study

    Cohort study

  28. Eur J Heart Fail

    Predicting Survival in Patients with Severe Heart Failure: Risk Score Validation in the HELP-HF Cohort

    Diagnostic or prognostic study

  29. Eur J Heart Fail

    Remote Patient Monitoring in Heart Failure: A Comprehensive Meta-Analysis of Effective Programme Components for Hospitalization and Mortality Reduction

    Meta-analysis

  30. Eur J Prev Cardiol

    Hepcidin, incident heart failure, and cardiac dysfunction in older adults: the ARIC study

    Cohort study

  31. Eur J Heart Fail

    Association of a Remote Monitoring Programme with All-Cause Mortality and Hospitalizations in Patients with Heart Failure: National-Scale, Real-World Evidence from a 3-Year Propensity Score Analysis of the TELESAT-HF Study

    Cohort study

  32. Eur Heart J

    Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study

    Cohort study

  33. Eur J Heart Fail

    Sacubitril/Valsartan Versus Valsartan Initiation in Patients Naïve to Renin–angiotensin System Inhibitors: Insights from PARAGLIDE-HF

    Secondary analysis

  34. Eur J Heart Fail

    Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry

    Cohort study

  35. Eur J Heart Fail

    Time-Varying Analyses of Survival and Outcomes in Patients with HeartMate 3 Left Ventricular Assist Devices

    Cohort study

  36. JACC Heart Fail

    Growth Differentiation Factor–15 Is Associated With Congestion-Related Anorexia and Weight Loss in Advanced Heart Failure

    Cohort study

  37. JACC Cardiovasc Imaging

    Molecular Stratification of Light-Chain Cardiac Amyloidosis With 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic Precision

    Cohort study

  38. J Am Coll Cardiol

    Contributors and Solutions to High Out-of-Pocket Costs for Heart Failure Medications: A State-of-the-Art Review

    Research article

  39. J Am Coll Cardiol

    Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis

    Cross-sectional study

  40. Eur J Heart Fail

    Metabolic Dysfunction-Associated Steatotic Liver Disease is Associated with Increased Risks of Heart Failure

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,201–1,240 of 1,928, newest first